健愉 冯, 玉山 朱, 陈 权, 凌 林家, Jianyu Feng, Yushan Zhu, Quan Chen, Jialing Lin
, 300074.
, 73126-0901.
Zhongguo Xi Bao Sheng Wu Xue Xue Bao. 2019 Aug;41(8):1477-1489. Epub 2019 Sep 12.
Apoptosis is an important biological process that plays a key role in the regulation of cell fate and homeostasis. The B-cell lymphoma-2 (Bcl-2) family proteins are important regulators of the apoptotic pathway, and their dysfunction is associated with a variety of diseases, including cancer, neurodegenerative and autoimmune diseases. In the past decade, a large number of research work on the physiological functions and atomic structures of Bcl-2 family proteins have been reported, which has deepened our understanding of the molecular mechanism and pathological significance of Bcl-2 family proteins. Recently, new drugs targeting different Bcl-2 proteins have been developed and used in clinics or tested in clinical trials. However, the complexity and diversity in functions and structures of Bcl-2 family have left many unsolved problems. This article summarizes current knowledge of the structure and function of Bcl-2 family proteins and discusses the pharmacological significance of Bcl-2 proteins as effective therapeutic targets.
细胞凋亡是一种重要的生物学过程,在细胞命运调控和内环境稳态中发挥关键作用。B细胞淋巴瘤-2(Bcl-2)家族蛋白是细胞凋亡途径的重要调节因子,其功能失调与多种疾病相关,包括癌症、神经退行性疾病和自身免疫性疾病。在过去十年中,已报道了大量关于Bcl-2家族蛋白生理功能和原子结构的研究工作,这加深了我们对Bcl-2家族蛋白分子机制和病理意义的理解。最近,针对不同Bcl-2蛋白的新药已被开发出来,并应用于临床或正在进行临床试验。然而,Bcl-2家族在功能和结构上的复杂性和多样性仍留下许多未解决的问题。本文总结了目前关于Bcl-2家族蛋白结构和功能的知识,并讨论了Bcl-2蛋白作为有效治疗靶点的药理学意义。